I attended but my connection was not stable, I think they removed royalty free(not 100% sure) and promised good corporate governance practice.
Posts tagged Value Pickr
Glenmark Life Sciences (03-08-2024)
The GLS plant in Ankleshwar is in industrial Area its not in civil or population Area, and surrounded by other industries and empty land marked for other industries. My understanding is that Nirma or Earlier Glenmark Pharma has substantial hold/ link in Gujarat Govt or Politics which can easily influence GSPC officials not to pursue plant closure vigorously but to take care of corrective steps. GLS management has also taken proactive steps for future. So matter can be treated as deemed resolved. Which may be formally announced after 20/30 days. Otherwise when Dr Rawjee stated that Ankleshwar Plant gives 65 percent share in production the stock might had till now reached 500 but it jump upward after concall. So Donot bother about this issue its already discounted. And its also a good learning lesson for management in future as this issue has put their reputation at stake,
My portfolio expert advise needed _/\_ (03-08-2024)
thanx for the reply and yes surely I am looking for oppurtunity to add some smallcap aswell.
My portfolio expert advise needed _/\_ (03-08-2024)
Seems like a fine mix to me 
There are core companies and there are some possible compounders.
Sectoral spread is also decent with a good mix of all Finance – Banks and Allied, IT-Tech, Utilities/Energy, Defence, FMCG, Pharma, Chemical, Engineering and Materials, Auto and Auto Ancillaries.
Marjorly around Large and Mid Caps … In future if the market corrects, you could consider adding some small caps as well … for the extra Alpha for the portfolio given that you are looking at long term horizon with 10 years or more.
-Ameya
Bull therapy 101-thread for technical analysis with the fundamentals (03-08-2024)
@phreakv6 – I know you recently sold your holdings in Sharda Motor Corp but was wondering if you still tracked its recent results. If yes, would appreciate your views on it. Since its spectacular run up, the valuation gap seems to be closed to an extent for the time being. However, from a technical perspective, it seems to be consolidating in a range at 10DMA and 20 DMA with low volumes, which might be a good thing.
https://www.bseindia.com/xml-data/corpfiling/AttachLive/75a73513-0bfb-48d0-bdda-97d1ef949eeb.pdf
Raman’s Portfolio – Review Appriciated (03-08-2024)
Current portfolio update.
(*Mark -New addition)
| Sl No | Company | Sector | % of Portfolio | View | Reson to buy |
|---|---|---|---|---|---|
| 1 | PNGS Gargi Fashion | Retail | 11.3% | Long Term | Same |
| 2 | E2E Networks | IT | 9.2% | Long Term | Same |
| 3 | Redtape | Retail | 9.0% | Long Term | Same |
| 4 | ACE | Capital Goods | 8.6% | Long Term | Same |
| 5 | Mrs.Bectors Food | FMCG | 7.1% | Long Term | Same |
| 6 | Frog Cellsat | Telecommunication | 6.1% | Long Term | Same |
| 7 | Poly Medicure | Healthcare | 5.9% | Long Term | Same |
| 8 | Aurionpro Solutions | IT | 5.5% | Long Term | Same |
| 9 | Shivalik Bimetal | Electronics | 4.5% | Long Term | Same |
| 10* | Jash Engineering | Water Equipments / Solution | 4.2% | Long Term | Water theme. Water is scarce commodity.Very unique product profile.Technocrate Management with growth ambition. |
| 11 | Brand Concepts | Retail | 3.7% | Long Term | Same |
| 12 | Lincoln Pharma | Pharma | 3.5% | Medium Term | Same |
| 13 | BEW Engineering | Capital Goods | 3.5% | Medium Term | Same |
| 14 | AMI Organics | Chemicals | 3.4% | Long Term | Same |
| 15* | DMR Hydro | Infra consulatancy | 3.2% | Medium Term | Infra play. Just taking bet on a very small microcap into growing infra sector. Promoter seems to be good with long aspirations. Nothing much info available. |
| 16* | Macfos | Platform business (Electronics equipment) | 3.1% | Medium Term | Very unique company into Electronics equipment trading. Huge market size. Young technoctate management with high growth ambition. Robu 2.0 is will be the growth driver in future. |
| 17* | Shree Pacetronix | Healthcare | 2.8% | Long Term | Unique comp with unique products. I couldnot found any indian comp manufacturing such products. High entry barrier. Products are critical to humen health. Market size is narrow but good. Valuation confort visible |
| 18 | Phantom Digi. Effect | Entertainment | 2.3% | Medium Term | Same |
| 19 | Aurangabad Distille | Alcoholic Beverages | 1.9% | Medium Term | Same |
| 20 | Magson Retail & Dist | Retail | 1.2% | Medium Term | Same |
My portfolio expert advise needed _/\_ (03-08-2024)
hey all, Following is my portfolio i need your expert suggestion on this.
I started my investing journey after reading Rich dad poor dad I started with mutual fund slowly sip’ing every month and also I didn’t knew much about analysing stocks after reading few books i read coffee can investing I liked the idea so I thought of implementing the idea that i read in the book and invested in stocks which are
jubliant foodworks – 489
dr lal pathlabs – 2675.3
berger paints -579
britannia industries – 3471
titan – 2643
pidilite – 2198
sbi life – 1180
balkrishna industries – 2078
astral – 1658
avanti feeds – 552
pi industries – 2754
aarti industries – 575
infy – 1455
amararaja -608
hcl tech – 977
I am thinking to do this exercise every 10 year of coffee can investing but as I see market changes quickly is it worth to hold on to this stocks and repeat the exercise every 10 year
Also i have some stocks that i call mother stocks as they hold many company insides them i also hold them and few stock that I bought in 2021-2023 just looking at future no fundamanental just pure future prediction
Stocks are
reliance – 2441
hul – 2252
infoedge – 4094
itc – 202
cams – 2211
icici bank – 719
ion exchange – 289
powergrid – 205
jio finance – 306
aarti pharmalabs – 487
hal – 1244
I aso hold mutual fund
motilal oswal flexi cap
hsbc midcap
hdfc index fund
I am still learing thanx in advance
Eris Lifesciences – 100% of sales from India Pharma Market (03-08-2024)
Eris Life’s abilities to integrate and turnaround the acquisitions are really really commendable. The kind of margin improvements seen across the acquired brands / companies post acquisition are just eye popping. They did the same with Oaknet Pharma a couple of yrs ago
I think ( personal opinion ), the management can drive a lot of shareholder value in medium term
Another company ( IMHO ) that’s on a similar path is Mankind Pharma ( post the BSV ltd’s acquisition ). Here too, the chances of a successful turnaround are great
Disc : holding both, biased, not SEBI registered , not a buy / sell recommendation
The harsh portfolio! (03-08-2024)
@harsh.beria93 hello sir , in past you made cash position arround 25% in expensive market.
So currently how much cash you hold in your portfolio? Thanks in advance